Search Results 1281-1290 of 47022 for %s
... S, Gersbach CA, Ebrahimkhani MR, Kelly JJ, Ronald JA, Morizane R, Gupta N, Shakeri-Zadeh A, Vo N, Saha K, Saxena S, Gamm DM, Sinha D, Tarantal AF ...
... S, Roswell RO, Rangasamy S, Saikus CE, Kon ZN, Pierce MJ, Husk G, Stevens GR, Maybaum S. Defining levels of care in cardiogenic shock. Front Cardiovasc Med ...
Madhira BR, Konala VM, Adapa S, Naramala S, Ravella PM, Parikh K, Gentile TC. Recent Advances in the Management of Smoldering Multiple Myeloma. World J ...
AbiMansour JP, Jaruvongvanich V, Velaga S, Alexander R, Storm AC, Topazian MD, Law RJ, Vargas Valls EJ, Bofill-Garcia AM, Abu Dayyeh BK, Chandrasekhara V. Lumen ...
Publications. Print. Huynh V, Zhang D, Raghunathan A, Hardcastle J, Smoley S, Isaacson M, Gandham M, Dasari S, Abdullaev Z, Aldape K, Quezado M, Pratt D ...
Kanj AN, Skalski JH. Gut Mycobiome and Asthma. J Fungi (Basel). 2024 Mar 1; 10 (3) Epub 2024 Mar 01. View PubMed; Gupta VK, Rajendraprasad S, Ozkan M, ...
A Phase 2b, Randomized, Double-blind Study Of Redasemtide (S-005151) In Adult Participants With Acute Ischemic Stroke (REvive) · Share · Facebook · Twitter.
Wright JA, Huang L, Katamesh BE, Yadav S, Singla A, Vincent A. Hypothesized pharmacogenomic and medication influences on tetrahydrocannabinol and ...
Escalante P, Ramaswamy S, Sanabria H, Soini H, Pan X, Valiente-Castillo O, Musser JM. Genotypic characterization of drug-resistant Mycobacterium tuberculosis ...
Martin-Castillo B, Verdura S, Llop-Hernandez A, Lupu R, Cuyas E, Menendez JA. Metabolic hallmarks of trastuzumab resistance. Expert Opin Ther Targets.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!